Literature DB >> 24033533

Protective immunity by oral immunization with heat-killed Shigella strains in a guinea pig colitis model.

Soumik Barman1, Hemanta Koley, Thandavarayan Ramamurthy, Manoj Kumar Chakrabarti, Sumio Shinoda, Gopinath Balakrish Nair, Yoshifumi Takeda.   

Abstract

The protective efficacy of and immune response to heat-killed cells of monovalent and hexavalent mixtures of six serogroups/serotypes of Shigella strains (Shigella dysenteriae 1, Shigella flexneri 2a, S. flexneri 3a, S. flexneri 6, Shigella boydii 4, and Shigella sonnei) were examined in a guinea pig colitis model. A monovalent or hexavalent mixture containing 1 × 10(7) of each serogroup/serotype of heat-killed Shigella cells was administered orally on Days 0, 7, 14 and 21. On Day 28, the immunized animals were challenged rectally with 1 × 10(9) live virulent cells of each of the six Shigella serogroups/serotypes. In all immunized groups, significant levels of protection were observed after these challenges. The serum titers of IgG and IgA against the lipopolysaccharide of each of the six Shigella serogroups/serotypes increased exponential during the course of immunization. High IgA titers against the lipopolysaccharide of each of the six Shigella serogroups/serotypes were also observed in intestinal lavage fluid from all immunized animals. These data indicate that a hexavalent mixture of heat-killed cells of the six Shigella serogroups/serotypes studied would be a possible broad-spectrum candidate vaccine against shigellosis.
© 2013 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  heat-killed Shigella cells; hexavalent Shigella immunogen; protective immunity; shigellosis

Mesh:

Substances:

Year:  2013        PMID: 24033533     DOI: 10.1111/1348-0421.12095

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  4 in total

1.  Vaccines against gastroenteritis, current progress and challenges.

Authors:  Hyesuk Seo; Qiangde Duan; Weiping Zhang
Journal:  Gut Microbes       Date:  2020-06-18

2.  Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.

Authors:  Subhra Chakraborty; Clayton Harro; Barbara DeNearing; Jay Bream; Nicole Bauers; Len Dally; Jorge Flores; Lillian Van de Verg; David A Sack; Richard Walker
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

3.  Live and heat-killed probiotic: effects on chronic experimental colitis induced by dextran sulfate sodium (DSS) in rats.

Authors:  Li-Xuan Sang; Bing Chang; Bing-Yuan Wang; Wei-Xin Liu; Min Jiang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation.

Authors:  Michael M Kämpf; Martin Braun; Dominique Sirena; Julian Ihssen; Linda Thöny-Meyer; Qun Ren
Journal:  Microb Cell Fact       Date:  2015-01-23       Impact factor: 5.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.